Table 1 Demographics of the population studied
Anesthesia | All | ||
|---|---|---|---|
Without opioid | With opioid | ||
n = 88 | n = 137 | n = 225 | |
Female; n (%) | 21 (23.9%) | 46 (33.6%) | 67 (29.8%) |
Age, years; median (Q1, Q3) | 6.9 (4.5, 11.3) | 6.6 (4.2, 10.7) | 6.8 (4.3, 11.0) |
Weight, kg; median (Q1, Q3) | 35.2 (17.4, 62.0) | 28.9 (17.0, 4.7) | 31.0 (17.0, 56.4) |
Height, cm; median (Q1, Q3) | 124.0 (100.0, 148.0) | 118.5 (100.0, 144.0) | 121.0 (100.0, 146.0) |
Race; n (%) | |||
Asian/Pacific | 1 (1.1%) | 3 (2.2%) | 4 (4.8%) |
Other/unknown | 19 (21.6%) | 20 (14.6%) | 39 (17.3%) |
Black | 8 (9.1%) | 13 (9.5%) | 21 (9.3%) |
Hispanic | 57 (64.8%) | 92 (67.2%) | 149 (66.2%) |
White | 3 (3.4%) | 9 (6.6%) | 12 (5.3%) |
AHI category; n (%) | |||
10–20 | 26 (29.6%) | 48 (35.6%) | 74 (33.2%) |
20–40 | 31 (35.2%) | 54 (40.0%) | 85 (38.1%) |
≥40 | 31 (35.2%) | 33 (24.4%) | 64 (28.7%) |
BMI; n (%) | |||
Underweight (<5%) | 2 (2.3%) | 6 (4.4%) | 8 (3.6%) |
Normal to overweight (5–95%) | 34 (39.1%) | 60 (44.1%) | 94 (42.2%) |
Obese (96–98%) | 13 (14.9%) | 18 (13.2%) | 31 (13.9%) |
Morbidly obese (≥99%) | 38 (43.7%) | 52 (38.2%) | 90 (40.4%) |
Race: Black; n (%) | 8 (9.1%) | 13 (9.5%) | 21 (9.3%) |
AHI ≥ 20; n (%) | 62 (70.4%) | 87 (64.4%) | 149 (66.8%) |
PSG SO2 < 80%; n (%) | 47 (58.8%) | 58 (48.7%) | 105 (52.8%) |
PSG EtCo2 ≥ 60 mmHg; n (%) | 5 (9.4%) | 14 (16.5%) | 19 (13.8%) |
Craniofacial anomaly; n (%) | 5 (5.7%) | 11 (8.3%) | 16 (7.1%) |
Neuromuscular disease; n (%) | 8 (9.1%) | 21 (15.3%) | 29 (12.9%) |
Genetic syndrome; n (%) | 28 (31.8%) | 28 (20.4%) | 56 (24.9%) |
Surgical technique; n (%) | |||
Extracapsular without coblation | 68 (77.3%) | 107 (78.1%) | 175 (77.8%) |
Extracapsular with coblation | 4 (4.5%) | 13 (9.5%) | 17 (7.6%) |
Intracapsular with coblation | 16 (18.2%) | 17 (12.4%) | 33 (14.7%) |
PICU admission; n (%) | 56 (63.6%) | 72 (52.6%) | 128 (56.9%) |